BRIEF published on 09/29/2025 at 10:39, 11 months 27 days ago Genmab va acquérir Merus pour 8 milliards de dollars Acquisition Investissement Oncologie Genmab Merus
BRIEF published on 09/29/2025 at 10:39, 11 months 27 days ago Genmab to Acquire Merus for USD 8 Billion Acquisition Investment Oncology Genmab Merus
PRESS RELEASE published on 09/29/2025 at 10:34, 11 months 27 days ago Genmab to Acquire HBM Portfolio Company Merus for USD 8 billion in Cash Genmab to acquire HBM portfolio company Merus for USD 8 billion in cash. Merus is known for its innovative oncology therapies. The transaction with Genmab represents a 41% premium on the closing price Acquisition Oncology HBM Healthcare Genmab Merus
BRIEF published on 09/16/2025 at 17:52, 1 year ago HBM Healthcare Investments AG Reports Modest Growth in September 2025 Financial Results Net Asset Value Investment Performance Share Price HBM Healthcare
BRIEF published on 09/16/2025 at 17:52, 1 year ago HBM Healthcare Investments AG annonce une croissance modeste en septembre 2025 Résultats Financiers Cours De L'action Performance Des Investissements HBM Santé Valeur Nette D'inventaire
PRESS RELEASE published on 09/16/2025 at 17:47, 1 year ago Key Figures 15.09.2025 HBM Healthcare Investments AG reports key figures for 15.09.2025 in CHF. NAV at 245.43, Share Price at 178.00, and Total Net Assets at 1,641 million. Performance percentages shown Performance HBM Healthcare Investments AG Key Figures CHF 15.09.2025
BRIEF published on 09/10/2025 at 08:40, 1 year ago Swixx BioPharma et Lundbeck forment un partenariat multirégional pour le SNC Marchés Émergents Swixx BioPharma Investissements Dans Les Soins De Santé Lundbeck Partenariat CNS
BRIEF published on 09/10/2025 at 08:40, 1 year ago Swixx BioPharma and Lundbeck Forge Multi-Regional CNS Partnership Emerging Markets Swixx BioPharma Healthcare Investments Lundbeck CNS Partnership
PRESS RELEASE published on 09/10/2025 at 08:35, 1 year ago HBM Portfolio Company Swixx BioPharma and Lundbeck Sign Multi-Regional CNS Partnership HBM Healthcare Investments announces partnership between Swixx BioPharma, Lundbeck for CNS therapies in South-East Europe, Turkey and Latin America Partnership HBM Healthcare Investments CNS Therapies Swixx BioPharma Lundbeck
BRIEF published on 09/01/2025 at 17:52, 1 year ago HBM Healthcare Investments AG publie ses chiffres clés d'août 2025 Performance NAV Cours De L'action Bourse Suisse HBM Santé
Published on 09/26/2026 at 01:00, 1 day 4 hours ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 1 day 6 hours ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 1 day 11 hours ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 1 day 14 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/26/2026 at 15:30, 13 hours 34 minutes ago QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 13 hours 34 minutes ago QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 13 hours 49 minutes ago Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 21 hours 19 minutes ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/26/2026 at 00:01, 1 day 5 hours ago Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 17:45, 1 day 11 hours ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 1 day 11 hours ago Availability of the 2026 half-year financial report
